Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
10x Genomics, Inc.
13G/A
TXG · 88025U109
|
5.2% |
10/7/2026
Event 9/30/2026
|
|||
| ARK Investment Management LLC | 5.2% | ||||
| Catherine D. Wood | 5.2% | ||||
|
Twist Bioscience Corp
13G/A
TWST · 90184D100
|
5.1% |
9/8/2026
Event 8/31/2026
|
|||
| ARK Investment Management LLC | 5.1% | ||||
| Catherine D. Wood | 5.1% | ||||
|
908 Devices Inc.
13G/A
MASS · 65443P102
|
5.3% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 5.3% | ||||
| Catherine D. Wood | 5.3% | ||||
|
Beam Therapeutics Inc.
13G/A
BEAM · 07373V105
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 10.0% | ||||
| Catherine D. Wood | 10.0% | ||||
|
Pacific Biosciences of California, Inc.
13G/A
PACB · 69404D108
|
9.6% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 9.6% | ||||
| Catherine D. Wood | 9.6% | ||||
|
Cerus Corp
13G/A
CERS · 157085101
|
9.0% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 9.0% | ||||
| Catherine D. Wood | 9.0% | ||||
|
Brera Holdings PLC
13G/A
BREA · G13311108
|
4.9% |
8/7/2026
Event 7/31/2026
|
|||
| ARK Investment Management LLC | 4.9% | ||||
| Catherine D. Wood | 4.9% | ||||
|
GeneDx Holdings Corp.
13G/A
WGS · 81663L200
|
5.3% |
8/7/2026
Event 7/31/2026
|
|||
| ARK Investment Management LLC | 5.3% | ||||
| Catherine D. Wood | 5.3% | ||||
|
Strata Critical Medical, Inc.
13G/A
SRTA · 092667104
|
3.2% |
7/8/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 3.2% | ||||
| Catherine D. Wood | 3.2% | ||||
|
Canton Strategic Holdings, Inc.
13G/A
CNTN · 432705309
|
4.7% |
7/8/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 4.7% | ||||
| Catherine D. Wood | 4.7% | ||||
|
Archer Aviation Inc.
13G/A
ACHR · 03945R102
|
4.9% |
5/7/2026
Event 4/30/2026
|
|||
| ARK Investment Management LLC | 4.9% | ||||
| Catherine D. Wood | 4.9% | ||||
|
Arcturus Therapeutics Holdings Inc.
13G/A
ARCT · 03969T109
|
10.4% |
5/7/2026
Event 4/30/2026
|
|||
| ARK Investment Management LLC | 10.4% | ||||
| Catherine D. Wood | 10.4% | ||||
|
CRISPR Therapeutics AG
13G/A
CRSP · H17182108
|
11.8% |
4/30/2026
Event 3/31/2026
|
|||
| ARK Investment Management LLC | 11.8% | ||||
| Catherine D. Wood | 11.8% | ||||
|
Tempus AI, Inc.
13G
TEM · 88023B103
|
5.4% |
3/6/2026
Event 2/28/2026
|
|||
| ARK Investment Management LLC | 5.4% | ||||
| Catherine D. Wood | 5.4% | ||||
|
PagerDuty, Inc.
13G/A
PD · 69553P100
|
0.2% |
3/6/2026
Event 2/28/2026
|
|||
| ARK Investment Management LLC | 0.2% | ||||
| Catherine D. Wood | 0.2% | ||||
|
Recursion Pharmaceuticals, Inc.
13G/A
RXRX · 75629V104
|
7.3% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 7.3% | ||||
| Catherine D. Wood | 7.3% | ||||
|
Intellia Therapeutics, Inc.
13G/A
NTLA · 45826J105
|
12.3% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 12.3% | ||||
| Catherine D. Wood | 12.3% | ||||
|
Veracyte, Inc.
13G/A
VCYT · 92337F107
|
4.9% |
1/8/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 4.9% | ||||
| Catherine D. Wood | 4.9% | ||||
|
Roku, Inc
13G/A
ROKU · 77543R102
|
4.5% |
1/8/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 4.5% | ||||
| Catherine D. Wood | 4.5% | ||||
|
Iridium Communications Inc.
13G/A
IRDM · 46269C102
|
3.9% |
12/5/2025
Event 11/30/2025
|
|||
| ARK Investment Management LLC | 3.9% | ||||
| Catherine D. Wood | 3.9% | ||||
|
Kodiak AI, Inc.
13G/A
KDK · 500081104
|
1.2% |
11/7/2025
Event 10/31/2025
|
|||
| ARK Investment Management LLC | 1.2% | ||||
| Catherine D. Wood | 1.2% | ||||
|
Quantum-Si Inc
13G/A
QSI · 74765K105
|
4.8% |
6/6/2025
Event 5/31/2025
|
|||
| ARK Investment Management LLC | 4.8% | ||||
| Catherine D. Wood | 4.8% | ||||
|
Adaptive Biotechnologies Corporation
13G/A
ADPT · 00650F109
|
2.9% |
6/6/2025
Event 5/31/2025
|
|||
| ARK Investment Management LLC | 2.9% | ||||
| Catherine D. Wood | 2.9% | ||||
|
Personalis, Inc.
13G/A
PSNL · 71535D106
|
8.1% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 8.1% | ||||
| Catherine D. Wood | 8.1% | ||||
|
Accolade, Inc.
13G/A
ACCD · 00437E102
|
0% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 0% | ||||
| Catherine D. Wood | 0% | ||||
|
Absci Corp
13G/A
ABSI · 00091E109
|
8.6% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 8.6% | ||||
| Catherine D. Wood | 8.6% | ||||
|
Repare Therapeutics Inc.
13G/A
RPTX · 760273102
|
4.7% |
2/14/2025
Event 12/31/2024
|
|||
|
Markforged Holding Corp
13G/A
MKFG · 57064N102
|
0% |
2/14/2025
Event 12/31/2024
|
|||
|
CareDx, Inc.
13G/A
CDNA · 14167L103
|
4.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Butterfly Network, Inc.
13G/A
BFLY · 124155102
|
4.7% |
1/10/2025
Event 9/30/2024
|
|||
|
Nurix Therapeutics Inc.
13G/A
NRIX · 67080M103
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Nextdoor Holdings, Inc.
13G/A
NXDR · 65345M108
|
3.7% |
1/10/2025
Event 9/30/2024
|
|||
|
Vuzix Corp
13G/A
VUZI · 92921W300
|
3.8% |
1/10/2025
Event 9/30/2024
|
|||
|
Ginkgo Bioworks Holdings, Inc.
13G/A
DNA · 37611X209
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Velo3D, Inc.
13G/A
VLD · 92259N104
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Verve Therapeutics, Inc.
13G/A
VERV · 92539P101
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
2U, Inc.
13G/A
TWOU · 90214J101
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Teladoc Health, Inc.
13G/A
TDOC · 87918A105
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
UiPath, Inc.
13G/A
PATH · 90364P105
|
4.5% |
1/10/2025
Event 9/30/2024
|
|||
|
SomaLogic, Inc.
13G/A
SLGC · 83444K105
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Invitae Corp
13G/A
NVTAQ · 46185L103
|
0% |
1/10/2025
Event 9/30/2024
|
|||